| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |